Table 1. Correlation between AP4 and L-plastin expression and clinicopathologic characteristics of PCa patients.
| Characteristics | Patient frequency (%) |
AP4 expression level |
L-plastin expression level |
||||
|---|---|---|---|---|---|---|---|
| Low | High | P-valuea | Low | High | P-valuea | ||
| Total cases | 136 | 44 (32.4%) | 92 (67.6%) | 38 (27.9%) | 98 (72.1%) | ||
| Age (years) | 0.342 | 0.816 | |||||
| <65 | 45 (33.1%) | 17 | 28 | 12 | 33 | ||
| ⩾65 | 91 (66.9%) | 27 | 64 | 26 | 65 | ||
| PSA level (μg/l) | 0.185 | 0.278 | |||||
| ⩽10 | 51 (37.5%) | 20 | 31 | 17 | 34 | ||
| >10 | 85 (62.5%) | 24 | 61 | 21 | 64 | ||
| Gleason score | 0.040* | 0.259 | |||||
| ⩽7 | 115 (84.5%) | 41 | 73 | 30 | 85 | ||
| >7 | 21 (15.5%) | 3 | 19 | 8 | 13 | ||
| Pathologic stage | 0.051 | 0.026* | |||||
| ⩽T2 | 65 (47.8%) | 27 | 40 | 24 | 41 | ||
| >T2 | 71 (52.2%) | 17 | 52 | 14 | 57 | ||
| Lymph-node status | 0.001* | 0.022* | |||||
| Negative | 99 (72.8%) | 40 | 59 | 33 | 66 | ||
| Positive | 37 (27.2%) | 4 | 33 | 5 | 32 | ||
a
Chi-square test, *P<0.05, **P<0.01
Bold values indicate statistically significant values.